Hybio Pharmaceutical’s Liraglutide Filing Accepted by NMPA, Becomes Domestic Leader in GLP-1 Analog
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that its market filing for liraglutide, a...
China-based Hybio Pharmaceutical Co., Ltd (SHE: 300199) announced that its market filing for liraglutide, a...
The Center for Drug Evaluation (CDE) has released the 61st batch of chemical generic reference...
The National Medical Products Administration (NMPA) has released the 56th batch of reference drugs for...
The National Medical Products Administration (NMPA) has released the 55th batch of reference drugs for...
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...